J&J vaccine blood-clot cases increase in US, as EU agency says benefits of shot outweigh risks - News Summed Up

J&J vaccine blood-clot cases increase in US, as EU agency says benefits of shot outweigh risks


In the U.S., the number of cases of blood-clot disorders linked to the vaccine has increased to nine, up from the six initially reported, according to a senior U.S. health official. Use of the J&J vaccine has been temporarily suspended on the recommendation of the Food and Drug Administration and Centers for Disease Control and Prevention. authorities issued a pause on the use of the J&J vaccine. The changes in a vaccine recipient’s cells cause an immune response to the coronavirus cells that protects a large percentage of recipients against the virus. The AstraZeneca vaccine hasn’t yet been authorized for use in the U.S.


Source: Mint April 20, 2021 17:57 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */